Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

Overview of attention for article published in Respiratory Research, September 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 public wall post.

This study forms part of the first complete characterization of the dose–response curve for glycopyrrolate (GP) delivered using…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.